You appear to be offline. Some data may be unavailable until your connection is restored.

ABT

Stock

Abbott Laboratories

Create price alert

Description

Abbott Laboratories is a multinational healthcare company that discovers, develops, manufactures and markets a broad range of medical products, including pharmaceuticals, branded generic medicines, diagnostic instruments and tests, nutritional foods and supplements, and medical devices such as cardiovascular, diabetes‑care and neuromodulation technologies. It operates primarily in the health‑care sector, with four main segments—Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Medical Devices—serving patients and providers in more than 160 countries. Abbott is a market leader in several areas, notably continuous glucose monitoring (FreeStyle Libre), point‑of‑care diagnostics, and a variety of nutrition brands, and it ranks among the largest U.S. health‑care firms by revenue and global footprint.

Quarterly Earnings

QuarterDateEPS
Q3 FY26Oct 21, 2026—
Q2 FY26Jul 16, 2026$1.31
Q1 FY26Apr 16, 2026$1.15
Q4 FY25Jan 22, 2026$1.50
Q3 FY25Oct 15, 2025$1.30

Stay ahead of ABT earnings

Get reminders ahead of ABT's next earnings report, so you always know when results are coming.